SPAP14E8.05c is expressed in E. coli via in vitro systems and purified for use in biochemical studies. Key attributes include:
Sequence:
MTPDQNALVLSFLLTVGGLIGYLRKKSKVSLIAGTALGANFAWASKLMERGSS QGINYAF YGSLVLLASSGPRFYKSRKPVPMILTVLGVISTWYFYRLWA
SPAP14E8.05c is primarily used in:
Stability: Requires strict storage at -20°C/-80°C to prevent degradation .
Expression Limitations: Produced in E. coli, which may not replicate post-translational modifications present in native S. pombe .
Functional Annotation: Requires further studies (e.g., gene knockouts, ChIP-seq) to elucidate its role in S. pombe .
Research priorities include:
Functional Characterization: Identifying interacting partners via yeast two-hybrid or mass spectrometry.
Structural Elucidation: Determining its 3D structure to reveal membrane-anchoring mechanisms.
Pathway Mapping: Investigating its potential role in conserved eukaryotic processes (e.g., DNA replication, stress response).
KEGG: spo:SPAP14E8.05c
Schizosaccharomyces pombe UPF0136 membrane protein P14E8.05c is a 101-amino acid transmembrane protein found in fission yeast (S. pombe strain 972 / ATCC 24843). The full amino acid sequence is: MTPDQNALVLSFLLTVGGLIGYLRKKSKVSLIAGTALGANFAWASKLMERGSSQGINYAFYGSLVLLASSGPRFYKSRKPVPMILTVLGVISTWYFYRLWA. The protein is classified as part of the UPF0136 protein family and is identified by UniProt accession number Q9P7G3 . As a membrane protein, it is likely involved in cellular processes related to membrane function, though its specific biological role remains to be fully characterized through targeted experimental approaches.
For recombinant SPAP14E8.05c, the recommended storage conditions are -20°C for standard use, with -80°C recommended for extended storage periods. The protein is typically supplied in a Tris-based buffer containing 50% glycerol that has been optimized for protein stability. When working with this protein, it is advisable to prepare working aliquots stored at 4°C that can be used for up to one week. Repeated freeze-thaw cycles should be strictly avoided as they can compromise protein integrity and activity . This approach minimizes structural degradation while maintaining functional properties for experimental applications.
When designing experiments with recombinant SPAP14E8.05c, proper replication serves multiple critical functions: providing estimates of experimental error, improving precision by reducing standard deviation of treatment means, and increasing the scope of inference. Distinguish between true biological replicates (independent experimental units treated identically) and technical subsamples (multiple measurements from the same experimental unit) .
For membrane protein studies, a minimum of three biological replicates is recommended, with increased replication necessary when exploring subtle phenotypic effects. The relative precision of different experimental designs can be calculated as:
Relative efficiency = (MSE₂/MSE₁) × (dfe₁/dfe₂)
Where MSE represents error mean square and dfe represents error degrees of freedom for the respective designs . This calculation helps determine the most efficient experimental approach while minimizing resource usage.
S. pombe has a well-characterized S-phase DNA damage checkpoint that is dependent on proteins like Rad3 (homolog to mammalian ATM/ATR) and Cds1 . To investigate potential roles of SPAP14E8.05c in this pathway, researchers should implement a systematic experimental approach:
Generate SPAP14E8.05c deletion or mutation strains using standard S. pombe genetic techniques
Subject wild-type and mutant cells to DNA damaging agents (UV irradiation at 254nm)
Monitor checkpoint activation through:
Flow cytometry to assess cell cycle progression
Western blot analysis of Cds1 phosphorylation status
Microscopy to examine nuclear morphology
The experimental design should include appropriate controls that discriminate between different types of DNA damage responses. This is particularly important since S. pombe exhibits differential responses to UV-irradiation (which causes base modifications repairable during G1 and S-phase) versus gamma-irradiation (which causes double-stranded breaks) .
To investigate SPAP14E8.05c's involvement in meiotic recombination, implement established S. pombe genetic assays that measure:
For intragenic recombination measurement, plate diluted spores on both selective and non-selective media (e.g., YEA for total viable spores and YEA+G for Ade+ spores). Calculate recombination frequency by dividing the concentration of selected recombinants by the concentration of total viable spores . This approach provides quantitative data on how SPAP14E8.05c influences meiotic recombination rates, which can be compared with known recombination pathway components.
Recent research indicates proteins like Rtf2 in S. pombe are important for replication fork stability and interact with mRNA processing factors . To investigate potential interactions between SPAP14E8.05c and replication fork processes:
Create double mutants with known replication barrier components (e.g., rtf1 and rtf2)
Employ 2D gel electrophoresis to visualize replication intermediates at known barrier sites
Assess genetic interactions through phenotypic analysis of single vs. double mutants
Perform co-immunoprecipitation studies to identify potential physical interactions with known barrier proteins
This approach would determine whether SPAP14E8.05c influences replication barrier activity, possibly through direct interactions or through effects on splicing of critical replication factors like rtf1, as has been demonstrated for Rtf2 .
Investigating protein-protein interactions for membrane proteins presents unique challenges due to their hydrophobicity and native lipid environment requirements. A multi-method approach is recommended:
| Method | Advantages | Limitations | Application to SPAP14E8.05c |
|---|---|---|---|
| Split-ubiquitin yeast two-hybrid | Specifically designed for membrane proteins | May produce false positives | Screen for initial interaction partners |
| Co-immunoprecipitation with crosslinking | Preserves weak/transient interactions | Requires specific antibodies | Verify interactions in native context |
| Proximity labeling (BioID/APEX) | Identifies spatial proximity in vivo | Requires fusion protein expression | Map local interactome |
| FRET/BRET | Measures direct interactions in live cells | Requires fluorescent protein fusions | Confirm direct interactions |
When designing these experiments, include appropriate controls with mutations in key domains of SPAP14E8.05c to distinguish specific from non-specific interactions. Verification across multiple methods significantly strengthens confidence in identified interaction partners.
Missing data in experiments with membrane proteins like SPAP14E8.05c can introduce significant bias. Implement the following systematic approach:
Document patterns of missingness through a comprehensive Table 1 that compares variables between complete and partial cases
Assess whether outcomes are associated with missingness patterns
Implement appropriate analytical strategies:
For data missing completely at random (MCAR): complete case analysis may be appropriate
For data missing at random (MAR): multiple imputation techniques
For data not missing at random (MNAR): sensitivity analyses with different assumptions
Analyzing subcellular localization data for membrane proteins requires specialized statistical approaches:
Implement quantitative image analysis rather than qualitative assessment
Use colocalization coefficients (Pearson's, Mander's) with appropriate statistical tests
For time-series localization studies, employ mixed-effects models that account for:
Fixed effects (experimental conditions)
Random effects (cell-to-cell variability)
Temporal autocorrelation
When reporting results, present both representative images and quantitative metrics with measures of uncertainty. Test for the normality of distribution in quantitative measures before applying parametric statistical tests, and consider non-parametric alternatives when assumptions are violated. This comprehensive approach provides robust evidence for SPAP14E8.05c localization patterns under various experimental conditions.
When designing knockout studies for SPAP14E8.05c, implement a multi-level control structure:
Wild-type controls (unmodified S. pombe)
Empty vector controls (for complementation studies)
Point mutant controls (with mutations in key functional domains)
Related gene knockouts (other UPF family proteins)
This nested control design allows discrimination between specific effects of SPAP14E8.05c loss versus general perturbations to membrane integrity or related pathways. Incorporate randomization in the experimental design to ensure that observed phenotypic differences are not confounded by external factors like culture conditions or measurement protocols . Document all control validation steps in supplementary materials to enhance reproducibility.
Antibody validation is critical for reliable detection of SPAP14E8.05c. Implement these methodological approaches:
Specificity validation:
Western blot comparing wild-type vs. knockout strains
Peptide competition assays
Orthogonal detection methods (mass spectrometry)
Sensitivity assessment:
Titration experiments with recombinant protein standards
Detection limit determination
Signal-to-noise ratio quantification
Reproducibility testing:
Intra-lab reproducibility (multiple experiments)
Inter-lab validation when possible
Batch-to-batch antibody variation assessment
Document all validation steps according to emerging minimum reporting standards for antibody validation in the scientific literature. This rigorous approach prevents misinterpretation of data due to antibody cross-reactivity or insufficient sensitivity.
Structural studies of membrane proteins require significant quantities of properly folded protein. Optimize expression using this systematic approach:
Expression system selection:
E. coli with specialized strains (C41/C43) for membrane proteins
Yeast systems (P. pastoris) for eukaryotic post-translational modifications
Cell-free systems for toxic proteins
Expression construct optimization:
Test multiple fusion tags (His, GST, MBP) at N- and C-termini
Include removable tags with specific protease sites
Consider codon optimization for expression host
Solubilization and purification strategy:
Screen detergent panels (DDM, LMNG, etc.)
Test nanodiscs or amphipols for detergent-free approaches
Implement multi-step purification with quality control at each step
Document protein yield, purity, and stability under different conditions to establish optimal protocols. The purified protein should be stored in buffer containing 50% glycerol at -20°C or -80°C for extended storage, with working aliquots maintained at 4°C for up to one week .
When faced with contradictory experimental results concerning SPAP14E8.05c function, implement this systematic resolution framework:
Methodological reconciliation:
Compare experimental conditions in detail (strain backgrounds, media, temperature)
Assess differences in measurement techniques and their sensitivities
Evaluate statistical approaches and sample sizes
Biological context analysis:
Consider genetic background differences that might reveal condition-specific functions
Examine potential redundancy with related proteins
Investigate environmental factors that might affect protein function
Hypothesis refinement:
Develop integrative models that accommodate seemingly contradictory observations
Design discriminating experiments that test competing hypotheses
Consider partial or context-dependent functions
This approach transforms contradictions into opportunities for deeper mechanistic understanding, potentially revealing condition-specific roles for SPAP14E8.05c that reconcile apparently conflicting observations.
Implement these quality control criteria for recombinant SPAP14E8.05c preparations:
| Quality Parameter | Method | Acceptance Criteria |
|---|---|---|
| Purity | SDS-PAGE/Coomassie | >95% single band |
| Identity | Mass spectrometry | Matches theoretical mass |
| Secondary structure | Circular dichroism | Appropriate for predicted structure |
| Oligomeric state | Size exclusion chromatography | Consistent with native state |
| Activity | Functional assay (if known) | Dose-dependent response |
| Stability | Thermal shift assay | Tm within expected range |
Batch-to-batch consistency should be documented through comparative analysis of these parameters. For membrane proteins, additional criteria include proper incorporation into liposomes or nanodiscs and appropriate orientation within these membrane mimetics.
Distinguishing direct from indirect effects of SPAP14E8.05c mutations requires a multi-faceted approach:
Temporal analysis:
Monitor phenotypes at multiple time points after perturbation
Use rapid induction/depletion systems to establish immediate versus delayed effects
Domain-specific mutations:
Create targeted mutations in functional domains rather than complete gene deletions
Implement structure-function analysis with point mutations targeting key residues
Rescue experiments:
Perform complementation with wild-type and mutant versions
Use orthologous proteins from related species to identify conserved functions
Direct interaction assessment:
Implement proximity labeling approaches to identify direct interaction partners
Perform in vitro binding studies with purified components
This systematic approach helps establish causality and delineate the direct functional roles of SPAP14E8.05c from secondary effects resulting from cellular adaptations to its absence.